FDA Inspection 1210103 — Lupin Limited
The FDA completed an inspection of Lupin Limited on July 11, 2023 in Nagpur. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- July 11, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Nagpur (India)
Citations
| ID | CFR | Description |
|---|---|---|
| 2401 | 21 CFR 211.194(a)(4) | Complete Test Data |
| 4404 | 21 CFR 211.194(a)(1) | Sample identification and other information |